These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17288950

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F, Satoh H, Shiraki K, Saitoh T, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H.
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [Abstract] [Full Text] [Related]

  • 43. Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction.
    Raman SV, Sparks EA, Baker PM, McCarthy B, Wooley CF.
    J Cardiovasc Magn Reson; 2007 Jun; 9(6):907-13. PubMed ID: 18066751
    [Abstract] [Full Text] [Related]

  • 44. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Dimitrow PP.
    Magn Reson Imaging; 2004 Nov; 22(9):1339. PubMed ID: 15607110
    [No Abstract] [Full Text] [Related]

  • 45. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K.
    Magn Reson Imaging; 2005 Jun; 23(5):701. PubMed ID: 16051047
    [No Abstract] [Full Text] [Related]

  • 46. Comparison of SSFP and IR GRE techniques for measurement of total myocardial mass-influence of applied contrast dosage and implication for relative infarct size assessment.
    Grothues F, Boenigk H, Ghanem A, Schwerdtfeger A, Bartels D, Alpers S, Tempelmann C, Klein HU.
    J Cardiovasc Magn Reson; 2007 Jun; 9(3):607-14. PubMed ID: 17365243
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study.
    Cocker MS, Abdel-Aty H, Strohm O, Friedrich MG.
    Heart; 2009 Dec; 95(23):1925-30. PubMed ID: 19710029
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Delayed contrast enhancement CMR imaging in apical hypertrophic cardiomyopathy.
    Jassal DS, Chaithiraphan V, Neilan TG, Cury RC.
    Int J Cardiol; 2006 Nov 10; 113(2):e56-7. PubMed ID: 16769137
    [No Abstract] [Full Text] [Related]

  • 55. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.
    Aquaro GD, Masci P, Formisano F, Barison A, Strata E, Pingitore A, Positano V, Spirito P, Lombardi M.
    Am J Cardiol; 2010 Feb 01; 105(3):392-7. PubMed ID: 20102955
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
    Dumont CA, Monserrat L, Peteiro J, Soler R, Rodriguez E, Bouzas A, Fernández X, Pérez R, Bouzas B, Castro-Beiras A.
    Am J Cardiol; 2007 May 15; 99(10):1454-7. PubMed ID: 17493479
    [Abstract] [Full Text] [Related]

  • 58. Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major.
    Pepe A, Positano V, Capra M, Maggio A, Pinto CL, Spasiano A, Forni G, Derchi G, Favilli B, Rossi G, Cracolici E, Midiri M, Lombardi M.
    Heart; 2009 Oct 15; 95(20):1688-93. PubMed ID: 19491092
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.